China Pediatric Pharmaceuticals, Inc. Files Application f
NASDAQ Listing
January 19, 2010 10:45 PM Eastern Time
XI’AN, China--(EON: Enhanced Online News)--China Pediatric Pharmaceuticals, Inc. (OTC Bulletin Board: CPDU) ("China Ped
Pharmaceuticals " or the "Company"), today announced it has applied for listing approval on the NASDAQ Capital Market (“NAS
“This is an important milestone for China Pediatric Pharmaceuticals, and we are committed to working with NASDAQ to fulfill all o
requirements,” said Mr. Jun Xia, Chairman and Chief Executive Officer. “As a senior exchange NASDAQ is well suited for high-gr
such as China Pediatric Pharmaceuticals that meet its stringent listing requirements. With a NASDAQ listing, our visibility will increa
investors who follow companies like ours, improving trading volume and liquidity. This should, in turn, attract new investors to our C
The application is subject to review by NASDAQ's Listing Qualifications Department for compliance with all NASDAQ Capital M
requirements. The Company's common stock will continue to trade on the OTC Bulletin Board under its current symbol, CPDU, un
notified of its acceptance. CPDU believes it satisfies all of the listing qualifications associated with this application. We hope to recei
on NASDAQ within two to three months.
About China Pediatric Pharmaceuticals, Inc.
China Pediatric Pharmaceuticals, Inc. has its headquarters in Xi’an, Shaanxi Province, China. The Company identifies, discovers, d
manufactures and distributes both prescription and over-the counter, including both conventional and Traditional Chinese Medicines
pharmaceutical products for the treatment of some of the most common ailments and diseases, with pediatric medicine as its focus.
Pharmaceuticals, Inc.’s manufacturing facility located in Baoji City, Shaanxi Province. The Company distributes its high value, brand
both prescription and OTC, through exclusive territory agents who sell our products directly to local pharmacies who in turn sell the
customers. For the